Kastelein Johannes Jacob Pieter bought NAMS
January 7, 2026 · Form 4 insider transaction
Kastelein Johannes Jacob Pieter bought 115,000 shares of NewAmsterdam Pharma Company N.V. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
115,000
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 7, 2026
Shares owned after115,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying the option will vest on Janaury 2, 2027, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.